The studies revealed a striking correlation between high ID1 expression and shorter overall survival (OS) and disease-free survival (DFS) in total patients with AML, as well as in specific subtypes such as M2 and M5 [18, 59, 60]. This evidence concerns the gene ID1 and acute myeloid leukemia.